baber/WOPTO huggingface dataset:
Patent CA-2526693-A1 (CA)
Title: Image capturing card shuffler
Inventor: MAHONEY DANIEL
IPC: A63F1/12
Filed: 2003-05-30
Abstract: The present invention features a playing card shuffling device (20), which through the use of a small image capturing means (30), captures an image of the face value of each card and stores the image in memory. This image is sorted in the format of a bit map image. The operator of the machine would b e able to recall through the use of a key pad (44), the images of the cards th at comprised the individual hands in the previous game. This feature allows for verification of a winning hand after a game has been completed. Thereby a quick recheck of hands before paying a winning hand is performed. The face value of each card is determined by character recognition software. These ca rd values would be stored in memory for archival access for use in monitoring t he randomness of the game and determining the number of winning hands.
Patent CA-2528239-A1 (CA)
Title: Mutants of the factor vii epidermal growth factor domain
Inventor: BLAJCHMAN MORRIS
IPC: C12N9/94
Filed: 2004-06-03
Abstract: The application relates to modified blood coagulation factor, sequencing encoding such modified factors, processes for their production, and related pharmaceutical compositions comprising such factors and their uses. More specifically, the application relates to mutations in the human FVII EGF-1 domain, wherein said mutations were analyzed for clotting activity, amidolytic activity and affinity of binding to full-length, relipidated human TF by competitive ELISA.
Patent CA-2528455-A1 (CA)
Title: Method and system for compensating for phase offset of an amplifier
Inventor: DEMIR ALPASLAN
IPC: H04L25/66
Filed: 2004-05-05
Abstract: A communication system including an amplifier (105), a receiver (110), an analog to digital converter (ADC 115) and an insertion phase variation compensation module (120). The amplifier receives a communication signal (150). If the amplifier is enabled, the amplifier amplifies the communication signal and outputs the amplified communication signal to the receiver. If the amplifier is disabled, the amplifier passes the communication signal to the receiver without amplifying it. The receiver outputs an analog complex signal to the ADC. The ADC outputs a digital complex signal to the insertion phase variation compensation module which counteracts the effects of a phase offset intermittently introduced into the communication signal when the amplifier is enabled or disabled.
Patent CA-2528952-A1 (CA)
Inventor: TERDY LASZLO
IPC: C07J1/00
Filed: 2004-04-29
Abstract: The invention relates to a process for the synthesis of high purity d-(17.alpha.)-13-ethyl-17~hydroxy-18,19-dinorpregn-4-ene-20-yne-3-one-oxime (further on norelgestromine) via acetylation of d-norgestrel at position 17, oximation of the oxo group at position 3 of the obtained 17-acetoxy derivative, and finally hydrolyzing the acetoxy group at position 17 of the obtained 3-oxime derivative. The process according to our invention is as follows: the starting material, d-(17.alpha.-17-hydroxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3~one (d-norgestrel) - purity 93-94 % - is acetylated with acetic anhydride in acetic acid, in the presence of zinc chloride and hydrogen chloride, or 70 % perchloric acid in an inert gas atmosphere, and after completion of the reaction the excess of acetic anhydride and the "enol acetate" by-product are decomposed with aqueous hydrochioric acid, then the formed d-(17.alpha.)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one is isolated from the reaction mixture by addition of ice-water, the precipitated product is filtered off, washed with water, dried, dissolved in dichloromethane or acetone and clarified with silica gel or aluminum oxide and charcoal, after filtration of the clarifier the resulted solution is concentrated and the residue is recrystallized, the obtained d-(17.alpha.)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one is reacted either with hydroxylammonium acetate or with hydroxylammonium chloride in the presence of sodium acetate, in acetic acid in nitrogen atmosphere under vigorous stirring for about 1 hour, after completion of the reaction water is added, the precipitated product is filtered off, washed with water, dried and recrystallized, the obtained d-(17.alpha.-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime is hydrolyzed with an equivalent amount of an alkali metal hydroxide in a C1-C4 alkanol solution, in nitrogen atmosphere between a temperature of about 5-38 ~C, under vigorous stirring, after completion of the reaction the mixture is diluted with water and the pH of the resulted suspension is adjusted to 7,5-9 with acetic acid, the precipitated product is filtered off, washed with water, dried, the crude product is dissolved in ethanol, clarified with charcoal, and after filtration of the clarifier water is added to the obtained solution, the precipitated high purity d-(17.alpha.)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime is filtered off, washed with water and in given case recrystallized from ethanol.
Patent CA-2529080-A1 (CA)
Title: Enhanced visibility cartridge with improved retainer
Inventor: KENNEDY DANIEL L
IPC: A61B17/128
Filed: 2005-12-09
Abstract: A substantially translucent cartridge is provided for retaining surgical clips, such as those used in surgical ligating procedures. The cartridge includes a polymeric composition base and a separable polymeric composition clip retainer supported by the base wherein the polymeric composition of the base and retainer includes a particulate, light diffusing material for imparting a substantially translucent optical effect for tendering, surgical clips visible within the cartridge. The polymeric composition may further include a radiopaque additive for rendering the cartridge imageable during radiographing.
Patent CA-2531400-A1 (CA)
Title: Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
Inventor: ENGLEMAN JAMES T
IPC: A01N63/50
Filed: 2004-07-06
Abstract: The present invention relates to the isolation and characterization of nucleotide sequences encoding novel insecticidal proteins secreted into the extracellular space from Bacillus thuringiensis and related strains. The proteins are isolated from culture supernatants of Bacillus thuringiensis and related strains and display insecticidal activity against coleopteran insects including Colorado potato beetle (Lymantria dispar) and Southern Corn Rootworm (Diabrotica undecempunctata). Insecticidal proteins encoded by nucleotide sequences that hybridize to the isolated and characterized nucleotide sequences are disclosed. Also disclosed are methods of making and using transgenic cells and plants comprising the novel nucleotide sequence of the invention.
Patent CA-2534242-A1 (CA)
Inventor: ZACCONE MARK A
IPC: D06F39/08
Filed: 2006-01-27
Abstract: A spraying device for a washing machine includes a body including a wall having an outer surface, a water inlet and a channel defined therein. The channel is in flow communication with the water inlet, and a plurality of nozzles extend through the wall and in flow communication with the channel. The washing machine includes a wash tub and a basket mounted within the wash tub. The basket is configured to rotate. The nozzles include an inlet, an outlet, an inner diameter, and an outer diameter. At least a portion of the outlet includes a surface substantially perpendicular to a flow of water through the nozzle, and the nozzles have a length longer than a thickness of the wall. At least a portion of the outlet is unitary with the wall outer surface.
Patent CA-2538314-A1 (CA)
Title: Dihydroflavonol-4-reductase
Inventor: MCGONIGLE BRIAN
IPC: C12N15/82
Filed: 2004-09-09
Abstract: This invention relates to an isolated nucleic acid fragment encoding a dihydroflavonol-4-reductase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of dihydroflavonol-4-reductase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the dihydroflavonol-4-reductase in a transformed host cell.
Patent CA-2538434-A1 (CA)
Inventor: YAMADA KOJI
IPC: A61P35/00
Filed: 2004-09-14
Abstract: A novel indolopyrrolocarbazole derivative. It is either a compound represented by the general formula [I]: [I] (wherein A is oxygen, NH, or CH2; R1 is a single bond, lower alkyl, lower alkenyl, lower alkynyl, etc.; R2 is phenyl, naphthyl, or an aromatic or aliphatic heterocycle which is a 5- or 6-membered ring containing at least one of nitrogen, sulfur, and oxygen (provided that the phenyl, naphthyl, and aromatic or aliphatic heterocycle may be substituted); and G is a pentose group or hexose group) or a pharmaceutically acceptable salt of the compound.
Patent CA-2539117-A1 (CA)
Title: Inhibitors of histone deacetylase
Inventor: MALLAIS TAMMY C
IPC: C07C255/60
Filed: 2004-09-24
Abstract: The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
Patent CA-2539122-A1 (CA)
Title: Molding composition and method of use
Inventor: SHAH SHIRISH
IPC: B22C1/02
Filed: 2004-09-20
Abstract: A slurry composition for a mold and method of use thereof. The slurry composition includes about 45% to about 80% by weight alumina, about 10% to about 30% by weight silicon carbide, and about 10% to about 50% by weight colloidal silica. In one aspect, the alumina component comprises a material selected from the group consisting of brown fused alumina, white fused alumina, tabular alumina, calcined alumina, and mixtures thereof. In another aspect, the composition includes fumed silica at 2% to about 5% by weight. The composition may also include a setting agent at 0.05% to about 2% by weight.
Patent CA-2540644-A1 (CA)
Title: A method of modulating cell survival, differentiation and/or synaptic plasticity
Inventor: BOCK ELISABETH
IPC: C12N5/0793
Filed: 2004-09-29
Abstract: The present invention relates to a method of modulating differentiation, adhesion and/or survival of the neural cell adhesion molecule (NCAM) presenting cells by providing compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM. The invention provides candidate compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM by using methods for screening and testing described in the application. The invention further relates to pharmaceutical compositions comprising compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM and to use of the pharmaceutical compositions and compounds for the modulation of differentiation, adhesion and/or survival of NCAM presenting cells.
Patent CA-2545584-A1 (CA)
Title: Methods and compositions for the treatment of metabolic disorders
Inventor: OPPENHEIMER DAN
IPC: A61K31/519
Filed: 2004-11-17
Abstract: The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the specification describes methods and compositions for treating various types of phenylketonurias using compositions comprising BH4. Combination therapies of BH4 and other therapeutic regimens are contemplated.
Patent CA-2547021-A1 (CA)
Inventor: WACHSMAN ODED
IPC: A61M25/10
Filed: 2004-05-27
Abstract: A catheter adapted for performing a task at a location inside a lumen, the catheter comprising: a) an outer sheath; b) a balloon capable of inflating inside the lumen when the catheter reaches the location; and c) a balloon inflation tube, which is attached to the balloon and carries a fluid which causes the inflating of the balloon, said balloon inflation tube running through the outer sheath, movable relative to the outer sheath, and stiff enough so that it can be used to push and pull the balloon relative to the outer sheath.
Patent CA-2548393-A1 (CA)
Title: Chemokine receptor binding compounds
Inventor: BOGUCKI DAVID
IPC: C07D405/06
Filed: 2004-12-13
Abstract: The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
Patent CA-2548468-A1 (CA)
Title: The use of dead cell material obtained from rhodamine-based photodynamic therapy in the treatment or prevention of immunologic disorders, infections and cancers
Inventor: VILLENEUVE LUC
IPC: A61K35/28
Filed: 2004-12-02
Abstract: The present invention relates to the use of PDT-treated cells (whole or fragments thereof) and/or supernatant thereof in the preparation of vaccines for immunoprotection or immunomodulation. More particularly, the use of PDT-treated cells (whole or fragments thereof) and/or supernatant thereof in the preparation of an immunologic compound for prevention, protection, prophylaxis or treatment of an immunological disorder, infection and/or a cancer in an individual, which comprises treatment of the individual cells or components thereof with a photoactivatable molecule selected from the group consisting of compounds I to XVIII, wherein the photoactivatable molecule is activated by a light of appropriate wavelength, thereby activating the photoactivatable molecule and causing prevention, protection, prophylaxis or treatment of the immunological disorder, infection and/or a cancer.
Patent CA-2549090-A1 (CA)
Inventor: WETTER HERMANN
IPC: B60N2/90
Filed: 2004-12-17
Abstract: A tension detector has a flexible strap (350) having its end stitched into a loop (352) that wraps round a central shaft (354). A U-shaped one-piece coil spring has two coiled end portions (356) and (358) wrapped round the shaft (354). The end portions (356) and (358) are inter-connected by a central stirrup (360). A tether strap (316) has a loop (362) sewn into its end which engages round the stirrup (360). The ends of the shaft (354) are journalled in side walls of a housing (366). Each side wall has an inwardly direct abutment projection (368). The upper surface of the housing (366) includes a window (370) through which an arcuate indicator (372) is visible. The indicator (372) has side legs (374) and (376) that are slidably mounted on the stirrup (360).  When the strap (316) is relaxed, the left hand end of the arcuate indicator (372) is visible through the window (370). When the strap (316) is tightened, the arcuate indicator (372) pivots to the position shown in Figure 11 in which its right hand end, which is of a different colour to its left hand end, is visible through the window (370), indicating that the strap (316) has been tightened adequately. In the event of a crash, the coiled end portions (356) and (358) of the spring over-ride the abutment projections (368) and partially unwrap from the shaft (354) so that an extended stirrup portion (360) projects from the housing (366).
Patent CA-2550536-A1 (CA)
Title: Personalization services for entities from multiple sources
Inventor: COLLART TODD
IPC: G06F17/00
Filed: 2004-12-15
Abstract: A method comprising receiving a request for content; searching for a plurality of entities (802, 804, 806, 808) in response to the received request, the plurality of entities (802, 804, 806, 808) each having entity metadata (810) associated therewith; and creating a collection (814), the collection (814) comprises the plurality of entities and collection metadata (812). A data structure embodied on a computer readable medium (800) comprising a plurality of entities (802, 804, 806, 808); entity metadata (810) describing each of the plurality of entities; a collection (814) containing each of the plurality of entities; and collection metadata (812) describing the collection.
Patent CA-2552171-A1 (CA)
Inventor: GAETA STEPHEN ANTHONY
IPC: B31B50/25
Filed: 2004-12-10
Abstract: Display case comprising a bottom panel (12) having an upper surface, a lower surface and eight rectilinear sides, front and rear walls (34, 36) each extending upwardly from one of said bottom panel sides and each separated therefrom by a scoreline (14, 22), side walls (40, 42) extending upwardly from at least two other of said bottom panel sides separated therefrom by scorelines (18, 26), four oblique side panels (50, 52, 64, 66) extending upwardly from said bottom panel but not being directly connected thereto, the bottom of each side wall being coextensive with one of said bottom panel sides, and the maximum height of said front and rear walls (34, 36) not extending to the maximum height of said side walls whereby allowing viewing of the interior of the display case.
Patent CA-2555304-A1 (CA)
Title: Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
Inventor: SHORTIS NICOLAS PETER
IPC: A61P1/12
Filed: 2005-02-04
Abstract: A method for the treatment or prophylaxis of non-inflammatory bowel diseases, diarrhoea-predominant irritable bowel syndrome or other non-specific bowel disorder is disclosed comprising administering to a patient in need of such treatment or prophylaxis an effective amount of balsalazide, or a 4-ASA or 5-ASA compound modified to include a 4-ABA side chain, or a salt or a derivative thereof, or a composition comprising balsalazide the modified compound, or a salt or a derivative thereof together with a suitable carrier. Use of balsalazide, a 4-ASA or 5-ASA compound modified to include a 4-ABA side chain, or a salt or derivative thereof, for the manufacture of a medicament for the treatment or prophylaxis of non-inflammatory bowel diseases, diarrhoea-predominant Irritable Bowel Syndrome or other non-specific bowel disorder is also disclosed.
Patent CA-2555372-A1 (CA)
Title: Method for producing 4-nitroimidazole compound
Inventor: SHINHAMA KOICHI
IPC: C07D233/92
Filed: 2005-02-15
Abstract: The present invention provides a method for producing a 4-nitroimidazole compound represented by general formula (1) at high yield and at high purity by a safe method causing few dangers such as explosion. The production method of the present invention comprises iodinating a 4-nitroimidazole compound represented by general formula (2): wherein each of X1 and X2 represents a chlorine atom or bromine atom, and then reducing the obtained 5-iodo-4-nitroimidazole compound represented by general formula (3): wherein X2 is the same as defined above.
Patent CA-2556544-A1 (CA)
Title: Injection molded roof rail
Inventor: DROUILLARD JAMES R
IPC: B60R9/04
Filed: 2005-03-10
Abstract: A roof rail for a motor vehicle roof includes an elongated main body portion (22) having an open channel (36, 37) extending between opposing first and second ends. An end portion is integrally formed with the main body portion at each of the first and second ends thereof for attaching the roof rail to the motor vehicle roof.
Patent CA-2557557-A1 (CA)
Title: Method and apparatus for generating configuration data
Inventor: JOHNSON PAUL THOMAS
IPC: G06F1/22
Filed: 2005-02-25
Abstract: A computer system (1) is described for programming and testing micro~controllers (8). The computer System (1) includes an interactive design environment (20) comprising a configuration module (22), an assembler (24), a compiler (26) and a debugger (28). The compiler (26), assembler (24) and debugger (28) all enable high level program data (30) to be converted into binary code and stored within a program store to control the functioning of a CPU included within a micro-controller (8). The configuration module (22) is such to enable a user to generate a configuration program (30) for storing values in registers for controlling the settings of inbuilt peripherals in the micro-controller (8) and the routing of signals to and from the peripherals.  The register values for routing signals are identified in a two stage process.  Firstly utilising the configuration module (22) a user identifies which peripherals are to be enabled. A user interface is then generated to illustrate possible configurations for routing the signals necessary for the identified set of peripherals. A user can then select which of the identified sets of configuration data should be used to generate a configuration program (20).
Patent CA-2558759-A1 (CA)
Title: Clinquant pour aube de turboreacteur
Inventor: REGHEZZA PATRICK
IPC: F01D5/32
Filed: 2006-09-12
Abstract: Clinquant (20) pour aube (14) de turbomachine comprenant deux branches (21A, 21B) aptes à venir envelopper les flancs du pied (16) de l'aube, et deux pattes (22) s'étendant respectivement à partir d'une extrémité des deux branches, ces deux pattes (22) étant repliées l'une vers l'autre et étant reliées entre elles de manière à les empêcher de se déplier. Avantageusement, ce clinquant (20) comprend une pièce de liaison (24) reliant lesdites pattes (22) de manière à les empêcher de se déplier. Cette pièce de liaison (24) est assemblée auxdites pattes (22) de manière à autoriser l'écartement des branches (21A, 21B) du clinquant. par exemple, la pièce de liaison est apte à s'étirer suivant la direction d'écartement (A) des branches (21A, 21B).
Patent CA-2558946-A1 (CA)
Title: Novel method for the preparation of embryoid bodies (ebs) and uses thereof
Inventor: KOLOSSOV EUGEN
IPC: C12N5/073
Filed: 2004-07-08
Abstract: Provided are means and methods for producing embryoid bodies (EBs) from multi-or pluripotent cells. In particular, a method of generating embryoid bodies (EBs) is described comprising agitation of a liquid suspension culture of multi- or pluripotent cells in a container until generation of cell aggregates, optionally diluting the suspension, and further agitation of the suspension until formation of El3s. Furthermore, the present invention relates to the use of the novel culturing method and EBs obtained thereby for a variety of applications including genomics, diagnostic assays, teratogenic/embryotoxicological and pharmacological assays as well as for the provision of tissue grafts.
Patent CA-2562152-A1 (CA)
Title: Process for the production of cyclic diketones
Inventor: BROCKBANK BEN
IPC: C07C17/23
Filed: 2005-04-29
Abstract: The present invention relates to a process for the preparation of compounds of formula (I), wherein the substituents are as defined in claim 1, by reacting a compound of formula (II), with a bromine or chlorine source to form a compound of formula (III), wherein X is chlorine or bromine; reacting that compound with water to form the compound of formula (IV), converting that compound, using a compound of formula (V), wherein M+ is the hydrogen cation or an alkali metal ion, alkaline earth metal ion or ammonium ion, into the compound of formula (VI), and treating that compound with a cyanide source in the presence of a base.
Patent CA-2562539-A1 (CA)
Title: Substituted cyclohexylcarboxylic acid derivatives
Inventor: SCHICK HANS
IPC: C07D209/18
Filed: 2005-05-06
Abstract: The invention relates to substituted cyclohexylcarboxylic acid derivatives, a method for the production thereof, medicaments containing these compounds, and to the use of substituted cyclohexylcarboxylic acid derivatives for producing medicaments.
Patent CA-2564709-A1 (CA)
Title: Fluid pressure sensing chamber
Inventor: SORENSEN GARY P
IPC: G01L19/14
Filed: 2006-10-20
Abstract: A pressure sensing chamber having a tubing extension with a reduced diameter portion extending through the chamber. The tubing contains a plurality of ports so as to allow the purging of air from the chamber, but the ports are sized so that bubbles entering the tubing cannot easily flow into the chamber. The reduced diameter portion creates a pressure differential between the holes. This differential pressure creates flow through the chamber under high liquid flow and turbulent liquid flow events.